EXIBIT: Oxaliplatin in Biliary Tract Cancer

Status Completed

Clinical Trial Summary

The primary objective is to evaluate the efficacy of the GEMOX treatment as 1st line therapy in patients with advanced biliary tract cancer based on response rate measured by the RECIST unidimensional criteria.

Secondary objectives are : Progression free survival, overall survival and safety.

Clinical Trial Description

n/a

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Biliary Tract Neoplasms

Clinical Trial Details

NCT number	NCT00174564
Study type	Interventional
Source	Sanofi
Contact
Status	Completed
Phase	Phase 2
Start date	April 2003
Completion date	September 2006

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT01950572` - Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
Completed	`NCT03101566` - Study of Nivolumab in Combination With Gemcitabine/Cisplatin or Ipilimumab for Patients With Advanced Unresectable Biliary Tract Cancer	Phase 2
Recruiting	`NCT05237193` - A Prospective Study of UCAD for Diagnosing Benign or Malignant Biliary Obstruction and Follow-up
Not yet recruiting	`NCT06037655` - Chemotherapy Combined With Adebrelimab and Mecapegfilgrastim in Neoadjuvant Treatment of Potentially Resectable BTC	Phase 2
Recruiting	`NCT04584008` - Targeted Agent Evaluation in Digestive Cancers in China Based on Molecular Characteristics	N/A
Completed	`NCT00196105` - Malignant Obstruction ZILVER Against Routine Therapy (MOZART I)	N/A
Completed	`NCT02558959` - Second-line Irinotecan and Capecitabine Versus Irinotecan for Gemcitabine and Cisplatin Refractory Biliary Tract Cancer	Phase 2
Completed	`NCT02829918` - Study of Nivolumab in Patients With Advanced Refractory Biliary Tract Cancers	Phase 2
Completed	`NCT02784353` - Clinical Outcomes of Preoperative and Postoperative Rehabilitation in the Patients With HBP Malignancy	N/A
Recruiting	`NCT05429203` - Comparison of Duodenoscope With Single-use Distal Cover and the Conventional Reusable Duodenoscope	N/A
Recruiting	`NCT02255669` - Fully Covered SEMS Versus Partially Covered SEMS With Anti-migration System for Malignant Distal Biliary Obstruction	N/A
Completed	`NCT01731821` - Nonstented Stump-closed vs Duct-to-Mucosa Pancreaticojejunostomy After Pancreaticoduodenectomy	Phase 3
Completed	`NCT00422409` - Endoscopic Stenting of Gastrointestinal Cancer	N/A
Terminated	`NCT02900248` - CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice
Recruiting	`NCT03063554` - EUS BD vs ERCP TP for Pancreatic Cancer	N/A
Terminated	`NCT02615210` - Mid-Atlantic Research Group Single-Operator Cholangioscopic Assessment of Biliary Strictures	N/A
Completed	`NCT04595058` - LAMS Choledochoduodenostomies: With or Without Coaxial Plastic Stent	N/A
Recruiting	`NCT04856761` - A Study of Capecitabine Versus S-1 as Adjuvant Therapy in Patients With Biliary Tract Carcinoma After Surgical Resection
Recruiting	`NCT03427242` - Apatinib for Advanced Biliary Carcinoma	Phase 2
Recruiting	`NCT05615818` - Personalized Medicine for Advanced Biliary Cancer Patients	Phase 3